Intracranial Embolism
8
0
0
3
Key Insights
Highlights
Success Rate
75% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 52/100
12.5%
1 terminated out of 8 trials
75.0%
-11.5% vs benchmark
38%
3 trials in Phase 3/4
0%
0 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (8)
Rheoparin-coated Tubing System for Minimized Extracorporeal Circulation (MECC)
Electrical Cardioversion of Recent Onset Atrial Fibrillation - Silent Thromboembolic Events, Reverse Atrial Remodeling
Evaluation of Cerebral Thrombembolism After TAVR
Dual AntiPlatelet Therapies for Prevention of Periinterventional Embolic Events in TAVI
A Registry Study of Shuxuening Injection Used in Hospitals in China
Effect of ARC1779 on Cerebral Microembolism in Patients Undergoing Carotid Endarterectomy
Incidence of Acute Cerebrovascular Events Using Either Minimized or Standard Cardiopulmonary Bypass Circuit
Ultrasound Enhanced Thrombolytic Therapy of Middle Cerebral Artery Occlusion